Full-Time

Technical Project Manager

Brown & Brown Insurance

Brown & Brown Insurance

5,001-10,000 employees

Provides risk management and insurance solutions

Compensation Overview

$130k - $180k/yr

Texas, USA

Remote

Travel may be required to support corporate projects.

Bachelor's, Associate's

Category
IT Operations (1)
Required Skills
Agile
ETL
REST APIs
HIPAA

Get referred to Brown & Brown Insurance

See people who can refer or advise you

Requirements
  • A Bachelor's degree in Information Technology, Computer Science, Engineering, or a related field, or an Associate's degree with equivalent professional experience, is required.
  • A minimum of five years of experience managing technical projects with hands-on experience leading software development platform implementations or modernization efforts is required.
  • Demonstrated proficiency with Project Management Institute project management principles, including formal budgeting, cost management, schedule control, and earned value analysis, is required.
  • The candidate must be able to lead cross-functional teams across multiple business domains and organizational verticals, including effective coordination outside of their primary subject matter expertise.
  • Working experience in the Employee Benefits industry is required.
  • A strong understanding of the software development lifecycle, including Agile, hybrid, and waterfall methodologies, is required.
  • The candidate must be able to travel as needed to support corporate projects.
  • Project Management Professional certification or an equivalent Project Management Institute credential is required.
Responsibilities
  • Lead the end-to-end delivery of software development platform projects, including architecture decisions, build/buy analysis, integration planning, and production deployment.
  • Coordinate internal resources and third-party vendors for the execution of multiple concurrent technical initiatives.
  • Ensure that all projects are delivered on time, within scope, and within budget.
  • Define project scope and objectives in collaboration with business stakeholders, development teams, and technical leads, ensuring technical feasibility and strategic alignment.
  • Develop and manage detailed project budgets, including cost forecasting, spend tracking, variance reporting, and financial escalation when constraints require adjustment.
  • Build and maintain detailed project plans with milestones, dependencies, resource models, and critical path analysis.
  • Manage changes to project scope, schedule, and costs using formal change control and verification techniques aligned with Project Management Institute standards.
  • Drive cross-functional collaboration across departments, business units, and subject matter domains, including areas outside direct vertical expertise, to ensure integrated delivery outcomes.
  • Measure and report project performance using appropriate tools, key performance indicators, and earned value management techniques.
  • Perform risk identification, assessment, and mitigation planning, and escalate issues to leadership as needed.
  • Establish and maintain productive relationships with third-party vendors, including contract performance management and deliverable accountability.
Desired Qualifications
  • A minimum of four (4) years of experience supporting pharmacy management, Pharmacy Benefits Management (PBM), or medical/provider operations is preferred.
  • Experience with enterprise data platforms, integration layers, application programming interfaces, extract, transform, load pipelines, or cloud-based development environments is preferred.
  • Previous experience managing vendor-led or outsourced software development engagements is preferred.
  • Familiarity with healthcare regulatory and compliance frameworks, including the Health Insurance Portability and Accountability Act, Health Information Trust Alliance, and Health Information Technology for Economic and Clinical Health Act, is preferred.
  • Experience with portfolio-level project governance and demand management practices is preferred.
  • Exposure to modern development toolchains and artificial intelligence-assisted development environments is preferred.
Brown & Brown Insurance

Brown & Brown Insurance

View

Brown & Brown provides risk management and insurance solutions to businesses and individuals through its Retail and Specialty Distribution segments. The company works by acting as an intermediary to identify specific risks and connect customers with tailored insurance policies that protect their assets. Unlike many competitors, it combines the scale of a large global brokerage with a decentralized culture that emphasizes local community involvement and a team-based approach to service. Its goal is to provide superior risk protection and long-term security for customers by consistently prioritizing their best interests.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Leeds, United Kingdom

Founded

1914

Get referred to Brown & Brown Insurance

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Accession synergies remain $30 million to $40 million for 2026.
  • Q2 2026 revenue surged 30.4% to $1.68 billion, driven by contingents.
  • July 22, 2026 AI partnerships target faster sales cycles and stronger margins.

What critics are saying

  • Morgan Stanley cut Brown & Brown to Underweight on July 6, 2026.
  • Organic revenue fell 0.7% in Q2 2026, exposing acquisition dependence.
  • Florida property sensitivity and middle-market competition pressure margins, growth, and talent retention.

What makes Brown & Brown Insurance unique

  • Brown & Brown combines national brokerage scale with 44 states and 14 countries.
  • Its acquisition machine delivered Accession and $410 million Q2 2026 revenue.
  • Management embeds Anthropic, McKinsey, and Accenture across workflows for AI productivity gains.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Student Loan Assistance

Tuition Reimbursement

Mental Health Support

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 14th, 2026
Brown & Brown stock trades at 15.04X P/E, below industry average of 16.51X

Brown & Brown shares are trading at a discount to the insurance brokerage industry, with a forward price-to-earnings ratio of 15.04X versus the industry average of 16.51X. The company has a market capitalisation of $23.96 billion. The stock has gained 27.4% over the past three months, outperforming the industry's 22.4% growth. Analysts' average price target of $76.44 suggests a potential 7.6% upside from recent levels. The Zacks Consensus Estimate projects 2026 earnings per share to increase 5.6% year-over-year, with revenues reaching $7.04 billion, up 19.2%. Growth is supported by increasing new business, strong client retention, and strategic acquisitions. The company's recent Accession acquisition contributed approximately $410 million to second-quarter 2026 revenues, with expected synergies of $30-$40 million in 2026.

Yahoo Finance
Aug 13th, 2026
Brown & Brown tops insurance brokers' revenue growth but misses Q2 estimates by 2.5%

Five insurance brokers stocks reported largely satisfactory Q2 earnings, with revenues beating analyst consensus estimates by 0.8% overall. Share prices have held steady, rising 2.1% on average since results were released. Brown & Brown reported revenues of $1.68 billion, up 30.4% year on year. However, this figure fell short of analyst expectations by 2.5%. Despite scoring the fastest revenue growth amongst peers, it had the weakest performance against analyst estimates. The stock has risen 2.7% since reporting and currently trades at $71.60. Ryan Specialty delivered the strongest Q2 performance, reporting revenues of $916.6 million, up 7.2% year on year and outperforming analyst expectations by 5.3%. The insurance brokerage industry benefits from rising risk complexity and regulatory scrutiny, though faces challenges from labour intensity and wage inflation.

Yahoo Finance
Aug 3rd, 2026
Brown & Brown Q2 revenue misses estimates at $1.68B despite 30% growth

Brown & Brown reported second quarter 2026 results that missed revenue expectations but showed strong year-on-year growth. Revenue rose 30.4% to $1.68 billion, below the $1.72 billion analyst estimate. Management attributed performance to strong contingent commissions, effective acquisition integration, and improved sales processes. CEO J. Powell Brown said the company's enhanced sales model is building momentum with aligned teams generating new business wins. Operating margin declined year-over-year to 22.9% from 24.2%, though the company made progress controlling expenses. Adjusted EBITDA of $611 million beat analyst estimates of $603.1 million. During the earnings call, analysts questioned MGA competition impacts, European expansion plans, and technology investment costs. Management stressed disciplined underwriting and confirmed synergy targets remain unchanged.

Yahoo Finance
Aug 1st, 2026
Brown & Brown reports Q2 revenue of $1.68B but trades 6.9% below fair value target of $75.63

Brown & Brown reported Q2 2026 results with revenue of $1.676 billion and net income of $288 million. The insurance broker's shares closed at $70.40, posting a 22.16% gain over 90 days but down 9.30% year-to-date and 23.00% over one year. Valuation models suggest a fair value of $75.63, indicating the stock is 6.9% undervalued. The company's diversified portfolio across geographies and business lines supports earnings stability. However, the price-to-earnings ratio of 19.8x exceeds both the US insurance industry average of 12.1x and the stock's fair ratio of 12.5x. Risks include rising pharmacy costs in benefits and potential Florida legislative changes that could pressure margins.

Yahoo Finance
Jul 29th, 2026
Brown & Brown shares jump 5% on 30% revenue growth despite slight miss

Brown & Brown shares jumped 5% after reporting second-quarter results. The insurance brokerage firm's revenue grew 30.4% year-over-year to $1.68 billion, slightly below analyst estimates of $1.72 billion. Adjusted earnings per share came in at $1.07, exactly meeting Wall Street expectations. The positive market reaction suggests investors focused on strong top-line growth and profit targets rather than the minor revenue miss. The shares are down 5.9% year-to-date and trading at $73.05, which is 28.8% below their 52-week high of $102.58 from July 2025. Last month, Morgan Stanley downgraded the stock to "Underweight", citing concerns about organic growth reset and a softer pricing cycle.